share_log

Anixa Biosciences Analyst Ratings

Anixa Biosciences Analyst Ratings

Anixa 生物科學分析師評級
Benzinga ·  2023/07/12 06:06
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/12/2023 275% HC Wainwright & Co. → $12 Reiterates Buy → Buy
06/19/2023 275% HC Wainwright & Co. → $12 Reiterates Buy → Buy
05/23/2023 275% HC Wainwright & Co. → $12 Reiterates Buy → Buy
04/18/2023 275% HC Wainwright & Co. → $12 Reiterates → Buy
04/18/2023 181.25% Chardan Capital → $9 Reiterates → Buy
03/23/2023 275% HC Wainwright & Co. $11 → $12 Maintains Buy
03/22/2023 181.25% Chardan Capital $8 → $9 Maintains Buy
02/28/2023 243.75% HC Wainwright & Co. → $11 Reiterates → Buy
12/23/2022 150% Chardan Capital → $8 Initiates Coverage On → Buy
04/12/2021 243.75% HC Wainwright & Co. → $11 Initiates Coverage On → Buy
03/23/2020 165.62% Aegis Capital → $8.5 Initiates Coverage On → Buy
12/30/2019 150% B. Riley Securities $11.25 → $8 Maintains Buy
日期 上行/下行 分析公司 目標價格變動 評級變化 上一頁/當前額定值
07/12/2023 275% HC Wainwright & Co. → 12 美元 重申 購買 → 購買
06/19/2023 275% HC Wainwright & Co. → 12 美元 重申 購買 → 購買
05/23/2023 275% HC Wainwright & Co. → 12 美元 重申 購買 → 購買
04/18/2023 275% HC Wainwright & Co. → 12 美元 重申 → 購買
04/18/2023 181.25% 查丹資本 → 9 美元 重申 → 購買
03/23/2023 275% HC Wainwright & Co. 11 美元 → 12 美元 維護
03/22/2023 181.25% 查丹資本 8 美元 → 9 美元 維護
02/28/2023 243.75% HC Wainwright & Co. → 11 美元 重申 → 購買
12/23/2022 150% 查丹資本 → 8 美元 開啓覆蓋範圍 → 購買
2021 年 12 月 4 日 243.75% HC Wainwright & Co. → 11 美元 開啓覆蓋範圍 → 購買
2020 年 3 月 23 日 165.62% 宙斯盾資本 → 8.5 美元 開啓覆蓋範圍 → 購買
2019 年 12 月 30 日 150% B. 萊利證券 11.25 美元 → 8 美元 維護

What is the target price for Anixa Biosciences (ANIX)?

Anixa Biosciences(ANIX)的目標價格是多少?

The latest price target for Anixa Biosciences (NASDAQ: ANIX) was reported by HC Wainwright & Co. on July 12, 2023. The analyst firm set a price target for $12.00 expecting ANIX to rise to within 12 months (a possible 275.00% upside). 9 analyst firms have reported ratings in the last year.

HC Wainwright & Co. 於2023年7月12日公佈了Anixa Biosciences(納斯達克股票代碼:ANIX)的最新目標股價。這家分析公司將目標股價定爲12.00美元,預計ANIX將在12個月內升至12個月內(可能上漲275.00%)。去年有9家分析公司公佈了評級。

What is the most recent analyst rating for Anixa Biosciences (ANIX)?

Anixa Biosciences(ANIX)的最新分析師評級是多少?

The latest analyst rating for Anixa Biosciences (NASDAQ: ANIX) was provided by HC Wainwright & Co., and Anixa Biosciences reiterated their buy rating.

Anixa Biosciences(納斯達克股票代碼:ANIX)的最新分析師評級由HC Wainwright & Co. 提供,Anixa Biosciences重申了他們的買入評級。

When is the next analyst rating going to be posted or updated for Anixa Biosciences (ANIX)?

Anixa Biosciences(ANIX)的下一個分析師評級何時公佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Anixa Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Anixa Biosciences was filed on July 12, 2023 so you should expect the next rating to be made available sometime around July 12, 2024.

分析師在進行了廣泛的研究(包括瀏覽公開財務報表、與Anixa Biosciences的高管和客戶交談以及聽取財報電話會議)後得出股票評級。大多數分析師每三個月進行一次評級,因此每家公司每年應該獲得4個評級。Anixa Biosciences的最後一次評級是在2023年7月12日提交的,因此你應該預計下一個評級將在2024年7月12日左右公佈。

Is the Analyst Rating Anixa Biosciences (ANIX) correct?

分析師對 Anixa Biosciences (ANIX) 的評級正確嗎?

While ratings are subjective and will change, the latest Anixa Biosciences (ANIX) rating was a reiterated with a price target of $0.00 to $12.00. The current price Anixa Biosciences (ANIX) is trading at is $3.20, which is within the analyst's predicted range.

儘管評級是主觀的,而且會發生變化,但Anixa Biosciences(ANIX)的最新評級得到了重申,目標股價爲0.00美元至12.00美元。Anixa Biosciences(ANIX)目前的交易價格爲3.20美元,在分析師的預測區間內。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論